Reuters logo
BRIEF-Neos therapeutics announces settlement with Actavis on Adzenys XR-ODT patent litigation
2017年10月18日 / 下午1点35分 / 1 个月前

BRIEF-Neos therapeutics announces settlement with Actavis on Adzenys XR-ODT patent litigation

Oct 18 (Reuters) - Neos Therapeutics Inc

* Neos Therapeutics announces settlement with Actavis on Adzenys XR-ODT patent litigation

* Neos Therapeutics - has granted actavis right to manufacture, market generic version of Adzenys XR-ODT under Actavis anda beginning on Sept 1, 2025

* Neos Therapeutics - ‍settlement & licensing agreement is confidential; agreement subject to submission to FTC and U.S. DOJ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below